Vnitr Lek 2024, 70(3):E13-E16 | DOI: 10.36290/vnl.2024.042

Is fibromyalgia a neurological disorder?

Štefan Alušík
Katedra vnitřního lékařství IPVZ, Praha

The article discusses new developments in fibromyalgia disease in terms of diagnosis, evaluation of clinical manifestation and treatment. The most important change is the elucidation of the pathophysiological mechanisms in the brain (nociplastic pain) that underlie the clinical manifestation of the symptoms, especially the widespread muscle and ligament pain. In clinical diagnosis, the biggest change has been the abandonment of the investigation of the so-called tender points and the use of newer diagnostic criteria. In drug therapy, we are particularly concerned with the use of pregabalin, duloxetine and milnacipran, their optimal dosage and side effects. Many eminent experts believe that the disease belongs in the hands of neurologists, not only in terms of the mechanism of origin, but also in terms of the treatment used, neurologists are best qualified to do so.

Keywords: fibromyalgia, nociplastic pain, pregabalin, duloxetine, milnacipran.

Accepted: April 29, 2024; Published: May 6, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Alušík Š. Is fibromyalgia a neurological disorder? Vnitr Lek. 2024;70(3):E13-16. doi: 10.36290/vnl.2024.042.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cohen H. Controversies and challenges in fibromyalgia: a review and a proposal. Ther Adv Musculoskelet Dis. 2017;9(5):115-127. Go to original source... Go to PubMed...
    2. Varrassi G, Rekatsina M, Perrot S, et al. Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? Cureus. 2023;15(9):e44852. Go to original source... Go to PubMed...
    3. Gowers WR: Lumbago: its lessons and analogues. BMJ 1904, i:117-121. Go to original source... Go to PubMed...
    4. Graham W. The fibrositis syndrome. Bull Rheum Dis. 1953;3(8):33-4.
    5. Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep. 2004;8(5):369-78. Go to original source... Go to PubMed...
    6. Bannwarth B, Blotman F, Roué-Le Lay K, et al. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 2009;76(2):184-187. Go to original source... Go to PubMed...
    7. Perrot S, Vicaut E, Servant D, Ravaud P. Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: The DEFI study (Determination of Epidemiology of Fibromyalgia). BMC Musculoskelet Disord. 2011;12:224. Go to original source... Go to PubMed...
    8. Häuser W, Hausteiner-Wiehle C, Henningsen P, et al. Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: A cross sectional study. J Psychosom Res. 2020;133:110111. Go to original source... Go to PubMed...
    9. Wolfe F, Brähler E, Hinz A, Häuser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken). 2013;65(5):777-85. Go to original source... Go to PubMed...
    10. Mas A, Carmona L, Valverde M, et al. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. 2008;26(4):519-526.
    11. Branco JC, Bannwarth B, Failde I, et al.Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39:448-453. Go to original source... Go to PubMed...
    12. Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey. PLoS One. 2015;10(9):e0138024. Go to original source... Go to PubMed...
    13. Nijs J, George SZ, Clauw, DJ et al.Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine, The Lancet Rheumatology. 2021;3(5):e383-e392. Go to original source... Go to PubMed...
    14. Nijs J, Malfliet A, Nishigami T. Nociplastic pain and central sensitization in patients with chronic pain conditions: a terminology update for clinicians. Braz J Phys Ther. 2023;27(3):100518. Go to original source... Go to PubMed...
    15. Albrecht DS, Forsberg A, Sandström A, et al. Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation. Brain Behav Immun. 2019;75:72-83. Go to original source... Go to PubMed...
    16. Mosch B, Hagena V, Herpertz S, Diers M. Brain morphometric changes in fibromyalgia and the impact of psychometric and clinical factors: a volumetric and diffusion-tensor imaging study. Arthritis Res Ther. 2023;25(1):81. Go to original source... Go to PubMed...
    17. Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int J Mol Sci. 2021;22(8):3891. Go to original source... Go to PubMed...
    18. Martínez-Lavín M. Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain? Clin Exp Rheumatol. 2021;39(2):422-425. Go to original source... Go to PubMed...
    19. Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382-1386. Go to original source... Go to PubMed...
    20. Martínez-Lavín M. Centralized nociplastic pain causing fibromyalgia: an emperor with no cloths? Clin Rheumatol. 2022;41(12):3915-3917. Go to original source... Go to PubMed...
    21. Martínez-Lavín M. Dorsal root ganglia: fibromyalgia pain factory? Clin Rheumatol. 2021;40(2):783-787. Go to original source... Go to PubMed...
    22. Buldyś K, Górnicki T, Kałka D, et al. What Do We Know about Nociplastic Pain? Healthcare (Basel). 2023;11(12):1794. Go to original source... Go to PubMed...
    23. Mariette X. Long COVID: a new word for naming fibromyalgia? Ann Rheum Dis. 2024; 2;83(1):12-14. Go to original source... Go to PubMed...
    24. Adawi M, Chen W, Bragazzi NL, et al. Suicidal Behavior in Fibromyalgia Patients: Rates and Determinants of Suicide Ideation, Risk, Suicide, and Suicidal Attempts-A Systematic Review of the Literature and Meta-Analysis of Over 390,000 Fibromyalgia Patients. Front Psychiatry. 2021;12:629417. Go to original source... Go to PubMed...
    25. Pomares FB, Funck T, Feier NA, et al. Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging. J Neurosci. 2017;37(5):1090-1101. Go to original source... Go to PubMed...
    26. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-172 Go to original source... Go to PubMed...
    27. Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46:319-29. Go to original source... Go to PubMed...
    28. Kaltsas G, Tsiveriotis K. Fibromyalgia. [Updated 2023 Nov 9]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279092/
    29. Goldenberg DL. Diagnosing Fibromyalgia as a Disease, an Illness, a State, or a Trait? Arthritis Care Res (Hoboken) 2019;71(3):334-336. Go to original source... Go to PubMed...
    30. Kang J, Choi S, Park D, Lee S. Disentangling Diagnosis and Management of Fibromyalgia. J Rheum Dis. 2022;29(1):4-13. Go to original source... Go to PubMed...
    31. Winslow BT, Vandal C, Dang L. Fibromyalgia: Diagnosis and Management. Am Fam Physician. 2023;107(2):137-144.
    32. Alorfi NM. Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials. Front Pharmacol. 2022;13:1017129. Go to original source... Go to PubMed...
    33. Migliorini F, Maffulli N, Knobe M, et al. Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis. Sci Rep. 2022;12(1):12148. Go to original source... Go to PubMed...
    34. Migliorini F, Maffulli N, Eschweiler J, et al. Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis. J Orthop Surg Res. 2023;18(1):504. Go to original source... Go to PubMed...
    35. Gupta H, Girma B, Jenkins JS, et al. Milnacipran for the Treatment of Fibromyalgia. Health Psychol Res. 2021;9(1):25532. Go to original source... Go to PubMed...
    36. Griffing GT. Fibromyalgia is not a rheumatologic disease anymore. Medscape J Med. 2008; 25;10(2):47.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.